Advertisement
IRMD vs LIVN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRMD is a Hold and LIVN is a Buy.
IRMD's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for IRMD turned positive on November 06, 2026. Looking at past instances where IRMD's MACD turned positive, the stock continued to rise in 41 of 54 cases over the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where IRMD's RSI Indicator exited the oversold zone, 12 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IRMD as a result. In 83 of 114 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
IRMD moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +11.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRMD advanced for three days, in 194 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
IRMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 198 of 262 cases where IRMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for IRMD crossed bearishly below the 50-day moving average on October 30, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 19 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 41 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 56 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. IRMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.847) is normal, around the industry mean (4.142). P/E Ratio (47.685) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.180) is also within normal values, averaging (11.253). Dividend Yield (0.009) settles around the average of (0.011) among similar stocks. P/S Ratio (12.315) is also within normal values, averaging (40.124).
LIVN's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for LIVN turned positive on October 09, 2026. Looking at past instances where LIVN's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on LIVN as a result. In 57 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
LIVN moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for LIVN crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.
Following a +1.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where LIVN advanced for three days, in 206 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 109 of 186 cases where LIVN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.
Bearish Trend Analysis
The 10-day RSI Indicator for LIVN moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 16 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 59%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 59 cases where LIVN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LIVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
LIVN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. LIVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 55 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.741) is normal, around the industry mean (4.142). P/E Ratio (26.084) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.899) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (2.954) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 86 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LIVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
IRMD | LIVN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 75 Overvalued | |
PROFIT vs RISK RATING 1..100 | 19 | 86 | |
SMR RATING 1..100 | 41 | 55 | |
PRICE GROWTH RATING 1..100 | 56 | 36 | |
P/E GROWTH RATING 1..100 | 56 | 79 | |
SEASONALITY SCORE 1..100 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LIVN's Valuation (75) in the Medical Specialties industry is in the same range as IRMD (85). This means that LIVN’s stock grew similarly to IRMD’s over the last 12 months.
IRMD's Profit vs Risk Rating (19) in the Medical Specialties industry is significantly better than the same rating for LIVN (86). This means that IRMD’s stock grew significantly faster than LIVN’s over the last 12 months.
IRMD's SMR Rating (41) in the Medical Specialties industry is in the same range as LIVN (55). This means that IRMD’s stock grew similarly to LIVN’s over the last 12 months.
LIVN's Price Growth Rating (36) in the Medical Specialties industry is in the same range as IRMD (56). This means that LIVN’s stock grew similarly to IRMD’s over the last 12 months.
IRMD's P/E Growth Rating (56) in the Medical Specialties industry is in the same range as LIVN (79). This means that IRMD’s stock grew similarly to LIVN’s over the last 12 months.
| IRMD | LIVN | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 75% | 4 days ago 59% |
| Stochastic ODDS (%) | 4 days ago 63% | 4 days ago 71% |
| Momentum ODDS (%) | 4 days ago 73% | 4 days ago 66% |
| MACD ODDS (%) | 4 days ago 76% | 4 days ago 70% |
| TrendWeek ODDS (%) | 4 days ago 77% | 4 days ago 68% |
| TrendMonth ODDS (%) | 4 days ago 81% | 4 days ago 66% |
| Advances ODDS (%) | 6 days ago 73% | 12 days ago 68% |
| Declines ODDS (%) | 13 days ago 60% | 4 days ago 74% |
| BollingerBands ODDS (%) | 4 days ago 71% | 4 days ago 73% |
| Aroon ODDS (%) | 4 days ago 76% | 4 days ago 59% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRMD’s FA Score shows that 1 FA rating(s) are green while LIVN’s FA Score has 0 green FA rating(s).
- IRMD’s FA Score: 1 green, 4 red.
- LIVN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRMD’s TA Score shows that 7 TA indicator(s) are bullish while LIVN’s TA Score has 6 bullish TA indicator(s).
- IRMD’s TA Score: 7 bullish, 3 bearish.
- LIVN’s TA Score: 6 bullish, 4 bearish.
Price Growth
IRMD (@Medical/Nursing Services) experienced а +12.56% price change this week, while LIVN (@Medical/Nursing Services) price change was +13.95% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.27%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was -7.48%.
Reported Earning Dates
IRMD is expected to report earnings on Feb 04, 2027.
LIVN is expected to report earnings on Feb 24, 2027.
Industries' Descriptions
@Medical/Nursing Services (-3.27% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
IRMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, IRMD has been loosely correlated with PHG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IRMD jumps, then PHG could also see price increases.
| Ticker / NAME | Correlation To IRMD | 1D Price Change % | ||
|---|---|---|---|---|
| IRMD | 100% | +0.90% | ||
| PHG - IRMD | 48% Loosely correlated | -0.52% | ||
| HBIO - IRMD | 45% Loosely correlated | -1.18% | ||
| LIVN - IRMD | 44% Loosely correlated | -1.26% | ||
| ATEC - IRMD | 43% Loosely correlated | -4.62% | ||
| TWST - IRMD | 41% Loosely correlated | +0.15% | ||
More | ||||
LIVN and
Correlation & Price change
A.I.dvisor indicates that over the last year, LIVN has been loosely correlated with CRL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LIVN jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To LIVN | 1D Price Change % | ||
|---|---|---|---|---|
| LIVN | 100% | -1.26% | ||
| CRL - LIVN | 48% Loosely correlated | +7.83% | ||
| PHG - LIVN | 44% Loosely correlated | -0.52% | ||
| STE - LIVN | 43% Loosely correlated | -0.72% | ||
| UFPT - LIVN | 42% Loosely correlated | +1.22% | ||
| NVST - LIVN | 42% Loosely correlated | +0.84% | ||
More | ||||